
Get exclusive money-saving offers and guides
Straight to your inbox
Updated
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Monash IVF Group Limited is a diagnostics & research business based in Australia. Monash IVF Group shares (MVF) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Monash IVF Group has a trailing 12-month revenue of around $145.4 million..
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
Since the stock market crash in March caused by coronavirus, Monash IVF Group's share price has had significant negative movement.
Its last market close was $0.58, which is 42.57% down on its pre-crash value of $1.01 and 52.63% up on the lowest point reached during the March crash when the shares fell as low as $0.38.
If you had bought $1,000 worth of Monash IVF Group shares at the start of February 2020, those shares would have been worth $441.63 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $588.83.
52-week range | $0.38 - $1.0162 |
---|---|
50-day moving average | $0.7528 |
200-day moving average | $0.6367 |
Target price | $1.31 |
PE ratio | 15.7778 |
Dividend yield | $0.05 (6.48%) |
Earnings per share (TTM) | $0.045 |
Standard brokerage - Australian shares
Competitive broker fees on Australian and international shares
Important: Share trading carries risk of capital loss.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of A$0.58 on 2020-10-22
1 week (2021-01-12) | -18.31% |
---|---|
1 month (2020-12-18) | -26.11% |
3 months (2020-10-19) | -4.13% |
6 months (2020-07-17) | 9.43% |
1 year (2020-01-17) | -43.96% |
---|---|
2 years (2019-01-18) | -38.62% |
3 years (2018-01-19) | -57.20% |
5 years (2016-01-19) | -60.14% |
Valuing Monash IVF Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Monash IVF Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Monash IVF Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Monash IVF Group shares trade at around 16x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Monash IVF Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $25.8 million (£0.0 million).
The EBITDA is a measure of a Monash IVF Group's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $145.4 million |
---|---|
Operating margin TTM | 15.39% |
Gross profit TTM | $50.9 million |
Return on assets TTM | 4.38% |
Return on equity TTM | 5.53% |
Profit margin | 8.06% |
Book value | 0.641 |
Market capitalisation | $276.6 million |
TTM: trailing 12 months
Dividend payout ratio: 49.03% of net profits
Recently Monash IVF Group has paid out, on average, around 49.03% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 6.48% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Monash IVF Group shareholders could enjoy a 6.48% return on their shares, in the form of dividend payments. In Monash IVF Group's case, that would currently equate to about A$0.05 per share.
While Monash IVF Group's payout ratio might seem fairly standard, it's worth remembering that Monash IVF Group may be investing much of the rest of its net profits in future growth.
The latest dividend was paid out to all shareholders who bought their shares by 5 March 2020 (the "ex-dividend date").
Over the last 12 months, Monash IVF Group's shares have ranged in value from as little as $0.38 up to $1.0162. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Monash IVF Group's is 1.6614. This would suggest that Monash IVF Group's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnosis and treatment of infertility, fertility research and treatment services, tertiary level prenatal diagnostic services, low intervention IVF services, and diagnostic ultrasound services. Monash IVF Group Limited was incorporated in 2014 and is based in Richmond, Australia.
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
Steps to owning and managing ETFS FANG+ ETF units.
Steps to owning and managing ETFS S&P Biotech ETF units.
Steps to owning and managing ETFS Reliance India Nifty 50 ETF units.
Steps to owning and managing BetaShares India Quality ETF units.